Published in World J Stem Cells on July 26, 2014
Intraocular pressure reduction and neuroprotection conferred by bone marrow-derived mesenchymal stem cells in an animal model of glaucoma. Stem Cell Res Ther (2015) 0.80
Treatment of Inherited Eye Defects by Systemic Hematopoietic Stem Cell Transplantation. Invest Ophthalmol Vis Sci (2015) 0.78
Mesenchymal stem cells for treating ocular surface diseases. BMC Ophthalmol (2015) 0.77
Corneal stromal stem cells reduce corneal scarring by mediating neutrophil infiltration after wounding. PLoS One (2017) 0.75
The Comparison of Adipose Stem Cell and Placental Stem Cell in Secretion Characteristics and in Facial Antiaging. Stem Cells Int (2016) 0.75
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55
A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell (2008) 18.18
Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood (2004) 13.79
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet (2008) 12.59
Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci (2006) 8.09
Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells (2007) 7.57
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol (2002) 6.92
Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation (1968) 5.52
Mesenchymal stromal cells: current understanding and clinical status. Stem Cells (2010) 4.79
The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs (2001) 4.31
Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol (2000) 4.27
Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells (2005) 4.26
Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol (2000) 3.94
Marrow stromal stem cells. J Clin Invest (2000) 2.85
Limbal stem cells of the corneal epithelium. Surv Ophthalmol (2000) 2.84
Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells (2009) 2.71
Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin Exp Immunol (2009) 2.60
Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med (2012) 2.19
Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol (2008) 2.17
Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol (2009) 2.15
Corneal transplantation. Lancet (2012) 2.13
Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardiol (2008) 2.13
The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy (2013) 1.99
Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-α stimulated gene/protein 6. Stem Cells (2011) 1.96
Proteoglycan synthesis by bovine keratocytes and corneal fibroblasts: maintenance of the keratocyte phenotype in culture. Invest Ophthalmol Vis Sci (1999) 1.95
Multipotent stem cells in human corneal stroma. Stem Cells (2005) 1.95
Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem Biophys Res Commun (2002) 1.89
The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells (2008) 1.77
Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation (2006) 1.64
The keratocyte: corneal stromal cell with variable repair phenotypes. Int J Biochem Cell Biol (2006) 1.62
Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc Natl Acad Sci U S A (2010) 1.52
Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells. Stem Cells (2005) 1.46
Perivascular multipotent progenitor cells in human organs. Ann N Y Acad Sci (2009) 1.43
Mesenchymal stromal cell 'licensing': a multistep process. Leukemia (2011) 1.42
Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy. Stem Cells Int (2012) 1.41
Altered KSPG expression by keratocytes following corneal injury. Mol Vis (2003) 1.38
Immunomodulatory properties of mesenchymal stem cells: cytokines and factors. Am J Reprod Immunol (2011) 1.35
Stem cell therapy restores transparency to defective murine corneas. Stem Cells (2009) 1.32
Concise review: Stem cells in the corneal stroma. Stem Cells (2012) 1.31
Mesenchymal cells from limbal stroma of human eye. Mol Vis (2008) 1.30
The role of chemokines in mesenchymal stem cell homing to myocardium. Stem Cell Rev (2012) 1.28
Cell therapy of congenital corneal diseases with umbilical mesenchymal stem cells: lumican null mice. PLoS One (2010) 1.26
Limbal stem cell transplantation: new progresses and challenges. Eye (Lond) (2008) 1.25
Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency. Biotechnol Bioeng (2011) 1.24
Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency. Ophthalmology (2004) 1.23
Epithelial stem cells in corneal regeneration and epidermal gene therapy. J Pathol (2009) 1.22
Isolation and expansion of human limbal stromal niche cells. Invest Ophthalmol Vis Sci (2012) 1.20
Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response. Mol Ther (2012) 1.19
Role of mesenchymal stromal cells in solid organ transplantation. Transplant Rev (Orlando) (2008) 1.17
Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Rev (2011) 1.16
Differentiation of rabbit bone marrow mesenchymal stem cells into corneal epithelial cells in vivo and ex vivo. Mol Vis (2009) 1.14
Role of mesenchymal stem cells on cornea wound healing induced by acute alkali burn. PLoS One (2012) 1.14
Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model. Arch Dermatol Res (2008) 1.14
Mesenchymal stem cell transplantation in a rabbit corneal alkali burn model: engraftment and involvement in wound healing. Eye (Lond) (2006) 1.14
Mesenchymal stem cells: from experiment to clinic. Fibrogenesis Tissue Repair (2011) 1.13
Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation. Am J Transplant (2012) 1.11
Characterization of endothelial-like cells derived from human mesenchymal stem cells. J Thromb Haemost (2007) 1.09
In vitro characteristics and in vivo immunosuppressive activity of compact bone-derived murine mesenchymal progenitor cells. Stem Cells (2006) 1.07
Reconstruction of the corneal epithelium with induced marrow mesenchymal stem cells in rats. Mol Vis (2010) 1.07
Bone marrow mesenchymal stem cells can differentiate and assume corneal keratocyte phenotype. J Cell Mol Med (2012) 1.06
Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation. Transpl Int (2008) 1.06
Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells. Stem Cell Rev (2012) 1.05
Mesenchymal stem cells in the human corneal limbal stroma. Invest Ophthalmol Vis Sci (2012) 1.04
Mesenchymal stem cells together with mycophenolate mofetil inhibit antigen presenting cell and T cell infiltration into allogeneic heart grafts. Transpl Immunol (2010) 1.04
Mesenchymal stem cells: angels or demons? J Biomed Biotechnol (2011) 1.04
Mesenchymal stem cells derived from human limbal niche cells. Invest Ophthalmol Vis Sci (2012) 1.02
Immune privilege of corneal allografts. Ocul Immunol Inflamm (2010) 1.01
Mesenchymal stem cells for cardiac therapy: practical challenges and potential mechanisms. Stem Cell Rev (2013) 1.00
Corneal surface reconstruction using adult mesenchymal stem cells in experimental limbal stem cell deficiency in rabbits. Acta Ophthalmol (2009) 0.99
Potential of human umbilical cord blood mesenchymal stem cells to heal damaged corneal endothelium. Mol Vis (2012) 0.98
Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model. Transpl Immunol (2011) 0.93
Cytokine secretion by human mesenchymal stem cells cocultured with damaged corneal epithelial cells. Cytokine (2009) 0.91
Kinetics and function of mesenchymal stem cells in corneal injury. Invest Ophthalmol Vis Sci (2012) 0.91
Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model. Exp Eye Res (2012) 0.91
Human mesenchymal stem cells differentiate into keratocyte-like cells in keratocyte-conditioned medium. Exp Eye Res (2012) 0.88
Stem cells isolated from the human stromal limbus possess immunosuppressant properties. Mol Vis (2012) 0.88
Mesenchymal stem cell therapy in diabetes mellitus: progress and challenges. J Nucleic Acids (2013) 0.88
Differentiation potential of limbal fibroblasts and bone marrow mesenchymal stem cells to corneal epithelial cells. Stem Cells (2014) 0.87
Bone marrow-derived progenitor cells promote corneal wound healing following alkali injury. Graefes Arch Clin Exp Ophthalmol (2007) 0.87
Mesenchymal stem cells: characteristics, sources, and mechanisms of action. Vet Clin North Am Equine Pract (2011) 0.87
In vitro simulation of corneal epithelium microenvironment induces a corneal epithelial-like cell phenotype from human adipose tissue mesenchymal stem cells. Curr Eye Res (2013) 0.87
Immune modulation of co-transplantation mesenchymal stem cells with islet on T and dendritic cells. Clin Exp Immunol (2010) 0.86
Umbilical cord lining stem cells as a novel and promising source for ocular surface regeneration. Stem Cell Rev (2011) 0.86
Characterization of ocular surface epithelial and progenitor cell markers in human adipose stromal cells derived from lipoaspirates. Invest Ophthalmol Vis Sci (2012) 0.82
Combined intrathymic and intravenous injection of mesenchymal stem cells can prolong the survival of rat cardiac allograft associated with decrease in miR-155 expression. J Surg Res (2013) 0.81
Rat allogeneic mesenchymal stem cells did not prolong the survival of corneal xenograft in a pig-to-rat model. Vet Ophthalmol (2009) 0.81
Mesenchymal stromal cells to promote kidney transplantation tolerance. Curr Opin Organ Transplant (2014) 0.80
Heterogeneity of the biological properties and gene expression profiles of murine bone marrow stromal cells. Int J Biochem Cell Biol (2013) 0.79
Effect of immunosuppression on outcome measures in a model of rat limbal transplantation. Invest Ophthalmol Vis Sci (2002) 0.78
Effects of bone marrow mesenchymal stem cells on cell proliferation and growth factor expression of limbal epithelial cells in vitro. Ophthalmic Res (2012) 0.78
Comparison of beneficial factors for corneal wound-healing of rat mesenchymal stem cells and corneal limbal stem cells on the xenogeneic acellular corneal matrix in vitro. Mol Vis (2012) 0.76